Yamamoto M, Serizawa T, Shuto T, Akabane A, Higuchi Y, Kawagishi J, et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol. 2014;15:387–95.
Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999;45:427–34.
Article CAS PubMed Google Scholar
Smart D. Radiation toxicity in the central nervous system: mechanisms and strategies for injury reduction. Semin Radiat Oncol. 2017;27:332–9.
Article PubMed PubMed Central Google Scholar
Milano MT, Grimm J, Niemierko A, Soltys SG, Moiseenko V, Redmond KJ, et al. Single- and multifraction stereotactic radiosurgery dose/volume tolerances of the brain. Int J Radiat Oncol Biol Phys. 2021;110:68–86.
Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2010;77:996–1001.
Sneed PK, Mendez J, Vemer-van den Hoek JGM, Seymour ZA, Ma L, Molinaro AM, et al. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J Neurosurg. 2015;123:373–86.
Lehrer EJ, Peterson JL, Zaorsky NG, Brown PD, Sahgal A, Chiang VL, et al. Single versus multifraction stereotactic radiosurgery for large brain metastases: an international meta-analysis of 24 trials. Int J Radiat Oncol Biol Phys. 2019;103:618–30.
Werner-Wasik M, Rudoler S, Preston PE, Hauck WW, Downes BM, Leeper D, et al. Immediate side effects of stereotactic radiotherapy and radiosurgery. Int J Radiat Oncol Biol Phys. 1999;43:299–304.
Article CAS PubMed Google Scholar
Arvold ND, Pinnell NE, Mahadevan A, Connelly S, Silverman R, Weiss SE, et al. Steroid and anticonvulsant prophylaxis for stereotactic radiosurgery: large variation in physician recommendations. Pract Radiat Oncol. 2016;6:e89-96.
Alongi F, Fiorentino A, Gregucci F, Corradini S, Giaj-Levra N, Romano L, et al. First experience and clinical results using a new non-coplanar mono-isocenter technique (HyperArc™) for Linac-based VMAT radiosurgery in brain metastases. J Cancer Res Clin Oncol. 2019;145:193–200.
Article CAS PubMed Google Scholar
Minniti G, Capone L, Nardiello B, El Gawhary R, Raza G, Scaringi C, et al. Neurological outcome and memory performance in patients with 10 or more brain metastases treated with a frameless linear accelerator (LINAC)-based stereotactic radiosurgery. J Neurooncol. 2020;148:47–55.
Minniti G, Scaringi C, Paolini S, Lanzetta G, Romano A, Cicone F, et al. Single-fraction versus multifraction (3 × 9 Gy) stereotactic radiosurgery for large (>2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis. Int J Radiat Oncol Biol Phys. 2016;95:1142–8.
Kanayama N, Ikawa T, Ohira S, Hirata T, Morimoto M, Ogawa K, et al. Volumetric reduction of brain metastases after stereotactic radiotherapy: prognostic factors and effect on local control. Cancer Med. 2022;11:4806–15.
Article PubMed PubMed Central Google Scholar
Ohira S, Ueda Y, Kanayama N, Isono M, Inui S, Komiyama R, et al. Impact of multileaf collimator width on dose distribution in HyperArc fractionated stereotactic irradiation for multiple (-) brain metastases. Anticancer Res. 2021;41:3153–9.
Komiyama R, Ohira S, Ueda H, Kanayama N, Masaoka A, Isono M, et al. Intra-fractional patient motion when using the Qfix Encompass immobilization system during HyperArc treatment of patients with brain metastases. J Appl Clin Med Phys. 2021;22:254–60.
Article PubMed PubMed Central Google Scholar
George EJS, Kudhail J, Perks J, Plowman PN. Acute symptoms after gamma knife radiosurgery. J Neurosurg. 2002;97:631–4.
Tokuuye K, Akine Y, Sumi M, Kagami Y, Murayama S, Nakayama H, et al. Fractionated stereotactic radiotherapy of small intracranial malignancies. Int J Radiat Oncol Biol Phys. 1998;42:989–94.
Article CAS PubMed Google Scholar
Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol. 2006;81:18–24.
Manning MA, Cardinale RM, Benedict SH, Kavanagh BD, Zwicker RD, Amir C, et al. Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int J Radiat Oncol Biol Phys. 2000;47:603–8.
Article CAS PubMed Google Scholar
Aoyama H, Shirato H, Onimaru R, Kagei K, Ikeda J, Ishii N, et al. Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int J Radiat Oncol Biol Phys. 2003;56:793–800.
Lutterbach J, Cyron D, Henne K, Ostertag CB. Radiosurgery followed by planned observation in patients with one to three brain metastases. Neurosurgery. 2003;52:1066–74.
Williams BJ, Suki D, Fox BD, Pelloski CE, Maldaun MVC, Sawaya RE, et al. Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J Neurosurg. 2009;111:439–48.
Nath SK, Lawson JD, Simpson DR, Vanderspek L, Wang J-Z, Alksne JF, et al. Single-isocenter frameless intensity-modulated stereotactic radiosurgery for simultaneous treatment of multiple brain metastases: clinical experience. Int J Radiat Oncol Biol Phys. 2010;78:91–7.
Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006;295:2483–91.
Article CAS PubMed Google Scholar
Rajakesari S, Arvold ND, Jimenez RB, Christianson LW, Horvath MC, Claus EB, et al. Local control after fractionated stereotactic radiation therapy for brain metastases. J Neurooncol. 2014;120:339–46.
Article CAS PubMed Google Scholar
Jimenez RB, Alexander BM, Mahadevan A, Niemierko A, Rajakesari S, Arvold ND, et al. The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity. Adv Radiat Oncol. 2017;2:391–7.
Article PubMed PubMed Central Google Scholar
de la Pinta C, Fernández-Lizarbe E, Sevillano D, Capúz AB, Martín M, Hernanz R, et al. Brain metastases: single-dose radiosurgery versus hypofractionated stereotactic radiotherapy: a retrospective study. J Clin Transl Res. 2020;6:6–13.
PubMed PubMed Central Google Scholar
Lerner EC, Srinivasan ES, Broadwater G, Haskell-Mendoza AP, Edwards RM, Huie D, et al. Factors associated with new-onset seizures following stereotactic radiosurgery for newly diagnosed brain metastases. Adv Radiat Oncol. 2022;7: 101054.
Article PubMed PubMed Central Google Scholar
Nei M, Bagla R. Seizure-related injury and death. Curr Neurol Neurosci Rep. 2007;7:335–41.
Murayi R, Chittiboina P. Glucocorticoids in the management of peritumoral brain edema: a review of molecular mechanisms. Childs Nerv Syst. 2016;32:2293–302.
Article PubMed PubMed Central Google Scholar
Kaal ECA, Vecht CJ. The management of brain edema in brain tumors. Curr Opin Oncol. 2004;16:593–600.
Article CAS PubMed Google Scholar
Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, et al. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest. 1993;91:153–9.
Article CAS PubMed PubMed Central Google Scholar
Park JS, Qiao L, Su ZZ, Hinman D, Willoughby K, McKinstry R, et al. Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways. Oncogene. 2001;20:3266–80.
Article CAS PubMed Google Scholar
Hanna A, Boggs DH, Kwok Y, Simard M, Regine WF, Mehta M. What predicts early volumetric edema increase following stereotactic radiosurgery for brain metastases? J Neurooncol. 2016;127:303–11.
Dietrich J, Rao K, Pastorino S, Kesari S. Corticosteroids in brain cancer patients: benefits and pitfalls. Expert Rev Clin Pharmacol. 2011;4:233–42.
Article CAS PubMed PubMed Central Google Scholar
Arbour KC, Mezquita L, Long N, Rizvi H, Auclin E, Ni A, et al. Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non-small-cell lung cancer. J Clin Oncol. 2018;36:2872–8.
Article CAS PubMed Google Scholar
Fokas E, Henzel M, Surber G, Kleinert G, Hamm K, Engenhart-Cabillic R. Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases. J Neurooncol. 2012;109:91–8.
Loghin M, Levin VA. Headache related to brain tumors. Curr Treat Options Neurol. 2006;8:21–32.
留言 (0)